The U.S. Food and Drug Administration (FDA or Agency) recently issued a revised final guidance document addressing Clinical Decision Support (CDS) Software (the 2026 CDS Guidance). The 2026 CDS ...
FDA has long expressed an interest in digital health products. The extent to which FDA should assert jurisdiction over digital health products, however, has been the subject of considerable debate.
The Clinical Decision Support Coalition comprises healthcare industry stakeholders – software developers, patient advocacy groups, clinical societies, providers and healthcare payers – working to ...
This morning the FDA released two guidance documents relating to the regulation of various digital health software devices. The first is a draft guidance outlining categories of clinical decision ...
An industry coalition has finalized guidelines on the design and development of medium-risk clinical decision support software that aren’t subject to Food and Drug Administration review. The aim of ...
The US Food and Drug Administration’s (FDA) final guidance on clinical decision support (CDS) software goes against the statutory language laid out in the 21 st Century Cures Act, according to a legal ...
The Clinical Decision Support Coalition penned a 21-page letter Feb. 5 urging the FDA to rewrite its guidance on clinical decision support software to avoid “overregulation.” The CDS Coalition — which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results